Zhengming Chen

Zhengming Chen

Cornell University

H-index: 37

North America-United States

About Zhengming Chen

Zhengming Chen, With an exceptional h-index of 37 and a recent h-index of 31 (since 2020), a distinguished researcher at Cornell University, specializes in the field of Biostatistics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Molecular, immunohistochemical and clinical determinants of urothelial carcinoma of the bladder with nested subtype

Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis

A Prospective Study of Tocilizumab for the Prevention of Graft Failure and Graft-Versus-Host Disease in Haplo-Cord Transplantation, As a Potential Alternative to Anti-Thymocyte …

Safety and Efficacy of Bridging Radiation Therapy in the Context of CD19 CART Therapy for Non-Hodgkin Lymphoma: Systematic Review and Meta-Analysis

Impact of Graft Source on Transplant Outcomes in Myelofibrosis

XPO1 enables adaptive regulation of mRNA export required for genotoxic stress tolerance in cancer cells

Efficacy and Toxicity of CD19 Chimeric Antigen Receptor T Cell Therapy for Lymphoma in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis

Transplantation and Cellular Therapy

Zhengming Chen Information

University

Position

Weill Cornell Medicine

Citations(all)

7518

Citations(since 2020)

5173

Cited By

3919

hIndex(all)

37

hIndex(since 2020)

31

i10Index(all)

87

i10Index(since 2020)

66

Email

University Profile Page

Google Scholar

Zhengming Chen Skills & Research Interests

Biostatistics

Top articles of Zhengming Chen

Molecular, immunohistochemical and clinical determinants of urothelial carcinoma of the bladder with nested subtype

European Urology

2024/3/1

Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis

2024/2/15

A Prospective Study of Tocilizumab for the Prevention of Graft Failure and Graft-Versus-Host Disease in Haplo-Cord Transplantation, As a Potential Alternative to Anti-Thymocyte …

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

2024/2/1

Jorge Contreras
Jorge Contreras

H-Index: 1

Zhengming Chen
Zhengming Chen

H-Index: 25

Safety and Efficacy of Bridging Radiation Therapy in the Context of CD19 CART Therapy for Non-Hodgkin Lymphoma: Systematic Review and Meta-Analysis

2024/2/1

Zhengming Chen
Zhengming Chen

H-Index: 25

Impact of Graft Source on Transplant Outcomes in Myelofibrosis

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

2024/2/1

Zhengming Chen
Zhengming Chen

H-Index: 25

Ghaith Abu-Zeinah
Ghaith Abu-Zeinah

H-Index: 8

XPO1 enables adaptive regulation of mRNA export required for genotoxic stress tolerance in cancer cells

Cancer Research

2024/1/2

Efficacy and Toxicity of CD19 Chimeric Antigen Receptor T Cell Therapy for Lymphoma in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis

2024/1/1

Zhengming Chen
Zhengming Chen

H-Index: 25

Peter Martin
Peter Martin

H-Index: 11

Transplantation and Cellular Therapy

2023

Zhengming Chen
Zhengming Chen

H-Index: 25

Patterns of Care and Impact of Initial Treatment in Peripheral T-Cell Lymphoma: Outcome Analysis from the Lymphoma Epidemiology of Outcomes (LEO) and Molecular Epidemiology …

Blood

2023/11/28

Outcomes of Contemporary Novel Agent and Stem Cell Transplantation in Relapsed/Refractory PTCL

Blood

2023/11/28

Impact of Graft Source [Cord Blood Supported By CD34+ Selected Cells (Haplo-Cord) Vs. Matched Donor] on Transplant Outcomes in Myelofibrosis

Blood

2023/11/28

Zhengming Chen
Zhengming Chen

H-Index: 25

Ghaith Abu-Zeinah
Ghaith Abu-Zeinah

H-Index: 8

Efficacy and toxicity of CD19 CAR-T cell therapy for lymphoma in solid organ transplant recipients: a systematic review and meta-analysis

2023/6/4

Zhengming Chen
Zhengming Chen

H-Index: 25

Peter Martin
Peter Martin

H-Index: 11

Retrospective analysis of R-DHAP/Ox and ASCT as salvage treatment for relapsed/refractory high risk follicular lymphoma.

2023/5/18

Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege

The Journal of clinical investigation

2023/5/1

Screening chest CT prior to allogenic hematopoietic stem cell transplantation

Transplantation and Cellular Therapy

2023/5/1

Zhengming Chen
Zhengming Chen

H-Index: 25

Epsilon toxin-producing Clostridium perfringens colonize the MS gut and epsilon toxin overcomes immune privilege

J Clin Invest

2023/2/28

A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas

The Journal of Clinical Investigation

2022/12/15

Phase 2 trial of acalabrutinib-lenalidomide-rituximab (ALR) with real-time monitoring of MRD in patients with treatment-naïve mantle cell lymphoma

Blood

2022/11/15

Patterns of care and clinical outcomes in peripheral T-cell lymphomas: the lymphoma epidemiology of outcomes (LEO) and molecular epidemiology resource (LEO-MER) prospective …

Blood

2019/11/13

Epigenetic Priming with 5-Azacytidine Prior to Allogeneic Stem Cell Transplantation for Myeloid Malignancies with In Vivo T Cell Depletion: Results of a Phase II Trial

Blood

2022/11/15

Zhengming Chen
Zhengming Chen

H-Index: 25

See List of Professors in Zhengming Chen University(Cornell University)